Healthcare investment banking is one of the most active, intellectually demanding, and well-compensated verticals in the industry. If you’ve ever wondered what healthcare bankers actually do, which banks dominate the sector, and how to break in without a science degree, this guide has the answers. Healthcare is also one of the most interesting groups to work in — the deals are complex, the stakes are high, and the industry is constantly evolving in ways that create consistent deal flow.
What Healthcare Investment Bankers Do
Healthcare bankers advise companies across the healthcare ecosystem on mergers, acquisitions, capital raises, and strategic transactions. The sector is so large and diverse that most healthcare banking groups further segment by sub-sector: biopharma, medical devices, healthcare services, healthcare IT, diagnostics, and life sciences tools are the most common.
The work follows the same general pattern as any banking group — pitch books, financial models, deal execution, client management — but with a significant layer of domain complexity. A banker advising on a pharmaceutical M&A transaction needs to understand clinical trial data, FDA approval pathways, patent cliffs, and drug pricing dynamics, not just financial statements. That complexity is both what makes the sector challenging and what makes it intellectually rewarding.
The Healthcare Sector Landscape: Sub-Sectors You Need to Know
Biopharmaceuticals
Biopharma is the highest-profile sub-sector in healthcare banking — it includes large-cap pharma companies (Pfizer, Merck, AstraZeneca), mid-cap specialty pharma, and clinical-stage biotech companies developing novel therapies. Deal flow here is driven by pipeline deals (licensing, co-development, acquisitions of early-stage assets), patent cliff-driven acquisitions (big pharma buying companies with approved drugs to replace revenues from going-generic drugs), and biotech IPOs.
Key concepts you need to know for biopharma: FDA approval stages (Phase I, II, III, NDA/BLA), probability of technical success (PTS) and risk-adjusted NPV models for valuing clinical-stage companies, patent expiry and generic competition dynamics, and the business model differences between large pharma, specialty pharma, and biotech.
Medical Devices and MedTech
The medical device sector includes companies that develop and sell physical devices used in diagnosis, monitoring, or treatment — surgical tools, implantable devices (pacemakers, stents), diagnostic imaging equipment, and increasingly, connected health technologies. Deal dynamics here are driven by hospital purchasing cycles, FDA clearance (510k) vs. approval (PMA) pathways, and the push toward less invasive procedures.
Large strategic acquirers like Medtronic, Abbott, and BD are perpetually active buyers. PE firms are also active in this space, particularly in lower-risk device companies with cleared products and recurring revenue streams.
Healthcare Services
Healthcare services covers the delivery side of healthcare: hospital systems, physician practice groups, home health, behavioral health, specialty pharmacy, dental, and vision care. This sub-sector is PE’s favorite healthcare hunting ground — the fragmented market structure creates enormous roll-up and consolidation opportunities, and the businesses tend to have stable, recurring cash flows that support leverage.
Key concepts: reimbursement dynamics (how providers get paid by insurance companies and government programs), payor mix (commercial vs. Medicare vs. Medicaid), same-store revenue growth, and the regulatory environment around corporate practice of medicine laws.
Healthcare IT and Digital Health
Healthcare IT includes electronic health record (EHR) companies, revenue cycle management platforms, clinical decision support tools, telemedicine platforms, and a growing universe of digital health startups. This sub-sector accelerated significantly post-COVID, and deal activity remains high as health systems continue modernizing their technology infrastructure.
Major Players: Which Banks Dominate Healthcare
Healthcare banking is a specialized field, and the rankings look different from general M&A league tables. The top players typically include:
- Goldman Sachs — elite healthcare practice with deep biopharma relationships
- Morgan Stanley — strong across biopharma, devices, and services
- J.P. Morgan — broad healthcare coverage with particular strength in large-cap deals
- Evercore — highly regarded independent advisory boutique with a strong healthcare team
- Lazard — well-regarded in biopharma advisory, particularly in cross-border deals
- Centerview Partners — premier boutique with exceptional healthcare franchise
- Leerink Partners — dedicated healthcare-focused boutique, particularly strong in biotech and pharma
- SVB Securities (formerly Cowen) — historically strong in biotech and life sciences
The dedicated healthcare boutiques (Leerink, Piper Sandler’s healthcare group, Guggenheim Healthcare) are worth knowing about — they can offer more direct sector exposure for analysts who are certain they want to specialize.
Key Deals and Deal Structures in Healthcare
Healthcare M&A has some deal structures that are unique to the sector.
Contingent Value Rights (CVRs)
CVRs are common in biopharma deals involving clinical-stage assets. When there’s uncertainty about whether a drug will receive FDA approval or hit commercial milestones, buyers and sellers can bridge valuation gaps with CVRs — essentially a contractual right to receive additional payment if specified conditions are met. Understanding CVRs and how they’re structured is essential for anyone wanting to work in biopharma M&A.
Licensing and Collaboration Agreements
Not all biopharma “deals” are full acquisitions. Many are licensing agreements where a large pharma company licenses the rights to develop or commercialize a drug from a smaller biotech in exchange for upfront payments and royalties. Bankers often advise on these transactions, which require understanding milestone structures, royalty rates, and co-promotion arrangements.
SPAC and IPO Activity in Biotech
Biotech has historically been one of the most active IPO sectors. Understanding how pre-revenue biotech companies are valued (typically on pipeline risk-adjusted NPV) and what drives the IPO window in biotech is important context for anyone in a healthcare coverage role.
How to Break Into Healthcare Investment Banking
Here’s the practical guide to actually getting a healthcare banking offer.
Do You Need a Science Background?
No — but it helps, and you need to compensate for it if you don’t have one. Pre-med, biology, chemistry, and biomedical engineering majors have a natural advantage in biopharma and medical device groups because they can engage credibly with the scientific aspects of deals. But plenty of successful healthcare bankers majored in economics, finance, or history. What matters is that you demonstrate genuine intellectual interest in the sector and have done the work to understand it.
Build Sector Knowledge Before You Apply
Read the healthcare trade press: STAT News, FiercePharma, FierceHealthcare, BioPharma Dive. Follow FDA approval announcements and major deal announcements. Understand a few major therapeutic areas (oncology and immunology are good starting points). Be able to speak intelligently about why drug X was acquired for $Y price and what the acquirer’s strategic rationale was. This kind of homework is immediately apparent in interviews.
Network Specifically with Healthcare Bankers
When you’re targeting a specific group, your networking needs to go deep — not just “I want to work in healthcare banking” but specific conversations with healthcare analysts and associates about the types of deals they work on, what distinguishes the group’s practice, and what backgrounds they look for in interns. Use LinkedIn and alumni networks to find people in these groups. Our networking guide walks through exactly how to approach these conversations.
Tailor Your Story to the Sector
Your “why healthcare banking” answer needs to be specific and authentic. Interviewers in specialized groups are evaluating whether you actually care about the sector or just picked healthcare because you thought it was a good answer. Reference specific deals, specific scientific trends, or specific aspects of the business that genuinely interest you. If you have relevant experience — research lab, hospital internship, pharma corporate development — make sure it’s prominent on your resume. Use our resume template as a starting point and ensure your healthcare-relevant experience is framed in the context of what a banking group cares about.
Ace the Technical Interview
In addition to standard banking technicals, healthcare interviews often include sector-specific questions: how to value a biotech with no revenue, how to think about a patent cliff in a pharma company’s model, what a CVR is and when you’d use one, and how reimbursement changes affect healthcare services valuations. Prepare for these alongside standard accounting and valuation questions. Our Technical Cheatsheet covers foundational concepts, and you should layer on healthcare-specific knowledge from your sector research.
Exit Opportunities From Healthcare Banking
Healthcare banking is an exceptional springboard. Exit opportunities include:
- Healthcare-focused PE firms (Bain Capital Life Sciences, OrbiMed, Deerfield, New Enterprise Associates)
- Healthcare hedge funds (Baker Brothers, RA Capital, Perceptive Advisors)
- Corporate development at pharma/biotech companies
- Venture capital in life sciences
- MBA programs, where healthcare banking credentials are highly valued
You can explore what paths our coached students have taken through our student interviews, and see a broader picture of our placement history on the WSMM track record page.
Want Personalized Interview Coaching?
Healthcare banking is competitive and sector-specific — the right preparation makes a significant difference. If you want expert help positioning yourself for healthcare groups, building your sector knowledge, and nailing the interviews, apply to work with Wall Street Mastermind. Read what students have said on Trustpilot and explore our program overview to see how we work.
